Clinical study to elucidate the efficacy of oral propranolol treatment for infantile hemangiomas
Not Applicable
- Conditions
- Infantile hemangiomas
- Registration Number
- JPRN-UMIN000012123
- Lead Sponsor
- Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patient who has a severe complication without infantile hemangiomas 2.Patient with the past of serious side effect by the propranolol drug 3.Patient with cardiac disease, asthma or carbohydrate metabolism 4.Patient who was considered ineligible by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in color and size of infantile hemangiomas, and side effects of propranolol treatment
- Secondary Outcome Measures
Name Time Method